|
1
|
Lan C, Chenggang W, Yulan B, Xiaohui D,
Junhui Z and Xiao W: Aberrant expression of WWOX protein in
epithelial ovarian cancer: a clinicopathologic and
immunohistochemical study. Int J Gynecol Pathol. 31:125–132. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vlahovic G, Meadows KL, Uronis HE, et al:
A phase I study of bevacizumab, everolimus and panitumumab in
advanced solid tumors. Cancer Chemother Pharmacol. 70:95–102. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Egawa-Takata T, Endo H, Fujita M, et al:
Early reduction of glucose uptake after cisplatin treatment is a
marker of cisplatin sensitivity in ovarian cancer. Cancer Sci.
101:2171–2178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park SS, Bae I and Lee YJ:
Flavonoids-induced accumulation of hypoxia-inducible factor
(HIF)-1alpha/2alpha is mediated through chelation of iron. J Cell
Biochem. 103:1989–1998. 2008. View Article : Google Scholar
|
|
5
|
Shin EK, Kwon HS, Kim YH, Shin HK and Kim
JK: Chrysin, a natural flavone, improves murine inflammatory bowel
diseases. Biochem Biophys Res Commun. 381:502–507. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lotito SB and Frei B: Dietary flavonoids
attenuate tumor necrosis factor alpha-induced adhesion molecule
expression in human aortic endothelial cells. Structure-function
relationships and activity after first pass metabolism. J Biol
Chem. 281:37102–37110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee SJ, Yoon JH and Song KS: Chrysin
inhibited stem cell factor (SCF)/c-Kit complex-induced cell
proliferation in human myeloid leukemia cells. Biochem Pharmacol.
74:215–225. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang T, Chen X, Qu L, Wu J, Cui R and
Zhao Y: Chrysin and its phosphate ester inhibit cell proliferation
and induce apoptosis in Hela cells. Bioorg Med Chem. 12:6097–6105.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Monasterio A, Urdaci MC, Pinchuk IV,
López-Moratalla N and Martínez-Irujo JJ: Flavonoids induce
apoptosis in human leukemia U937 cells through caspase- and
caspase-calpain-dependent pathways. Nutr Cancer. 50:90–100. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Khoo BY, Chua SL and Balaram P: Apoptotic
effects of chrysin in human cancer cell lines. Int J Mol Sci.
11:2188–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng X, Meng WD, Xu YY, Cao JG and Qing
FL: Synthesis and anticancer effect of chrysin derivatives. Bioorg
Med Chem Lett. 13:881–884. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng X, Cao JG, Liao DF, Zhu BY and Liu
HT: Synthesis and anticancer effect of gem-difluoromethylenated
chrysin derivatives. Chin Chem Lett. 11:1431–1442. 2006.In
Chinese.
|
|
13
|
Xiang H, Zheng X and Cao J: Induction of
apoptosis of human gastric carcinoma SGC-7901 cell line by
8-bromo-7-methoxychrysin. Zhongguo Yaolixue Tongbao. 24:1370–1373.
2008.
|
|
14
|
Ai XH, Zheng X, Tang XQ, et al: Induction
of apoptosis of human gastric carcinoma SGC-7901 cell line by 5,
7-dihydroxy-8-nitrochrysin in vitro. World J Gastroenterol.
13:3824–3828. 2007.PubMed/NCBI
|
|
15
|
Yang XH, Zheng X, Cao JG, Xiang HL, Liu F
and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of
hepatocellular carcinoma cells involves ROS and JNK. World J
Gastroenterol. 16:3385–3393. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao G, Tang X, Yao C and Wang C:
Potentiation of arsenic trioxide-induced apoptosis by
8-bromo-7-methoxychrysin in human leukemia cells involves depletion
of intracellular reduced glutathione. Acta Biochim Biophys Sin
(Shanghai). 43:712–721. 2011. View Article : Google Scholar
|
|
17
|
Staal SP: Molecular cloning of the akt
oncogene and its human homologues AKT1 and AKT2: amplification of
AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci
U S A. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: new opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levanon K, Crum C and Drapkin R: New
insights into the pathogenesis of serous ovarian cancer and its
clinical impact. J Clin Oncol. 26:5284–5293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Landen CN Jr, Birrer MJ and Sood AK: Early
events in the pathogenesis of epithelial ovarian cancer. J Clin
Oncol. 26:995–1005. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Connor L, Strasser A, O'Reilly LA, et
al: Bim: a novel member of the Bcl-2 family that promotes
apoptosis. EMBO J. 17:384–395. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qi XJ, Wildey GM and Howe PH: Evidence
that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL
apoptotic function. J Biol Chem. 281:813–823. 2006. View Article : Google Scholar
|
|
23
|
Fletcher JI and Huang DC: Controlling the
cell death mediators Bax and Bak: puzzles and conundrums. Cell
Cycle. 7:39–44. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
van Gorp AG, Pomeranz KM, Birkenkamp KU,
Hui RC, Lam EW and Coffer PJ: Chronic protein kinase B (PKB/c-akt)
activation leads to apoptosis induced by oxidative stress-mediated
Foxo3a transcriptional up-regulation. Cancer Res. 66:10760–10769.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Essafi A, Fernàndez de Mattos S, Hassen
YA, et al: Direct transcriptional regulation of Bim by FoxO3a
mediates STI571-induced apoptosis in Bcr-Abl-expressing cells.
Oncogene. 24:2317–2329. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cardone MH, Roy N, Stennicke HR, et al:
Regulation of cell death protease caspase-9 by phosphorylation.
Science. 282:1318–1321. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sunters A, Fernàndez de Mattos S, Stahl M,
et al: FoxO3a transcriptional regulation of Bim controls apoptosis
in paclitaxel-treated breast cancer cell lines. J Biol Chem.
278:49795–49805. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Simonin K, Brotin E, Dufort S, et al:
Mcl-1 is an important determinant of the apoptotic response to the
BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian
carcinoma cells. Mol Cancer Ther. 8:3162–3170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang N, Wu ZM, McGowan E, et al: Arsenic
trioxide and cisplatin synergism increase cytotoxicity in human
ovarian cancer cells: therapeutic potential for ovarian cancer.
Cancer Sci. 100:2459–2464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Z, Ahmad A, Banerjee S, et al: FoxM1
is a novel target of a natural agent in pancreatic cancer. Pharm
Res. 27:1159–1168. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ning Y, Li Q, Xiang H, Liu F and Cao J:
Apoptosis induced by 7-difluoromethoxyl-5,4′-di-n-octyl genistein
via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep.
27:1857–1864. 2012.PubMed/NCBI
|
|
32
|
Polier G, Ding J, Konkimalla BV, et al:
Wogonin and related natural flavones are inhibitors of CDK9 that
induce apoptosis in cancer cells by transcriptional suppression of
Mcl-1. Cell Death Dis. 2:e1822011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao XC, Cao XC, Liu F, et al: Regulation
of the FOXO3a/Bim signaling pathway by 5,7-dihydroxy-8-nitrochrysin
in MDA-MB-453 breast cancer cells. Oncol Lett. 5:929–934.
2013.PubMed/NCBI
|
|
34
|
Yuan Z, Wang F, Zhao Z, et al:
BIM-mediated Akt phosphorylation is a key modulator of arsenic
trioxide-induced apoptosis in cisplatin-sensitive and -resistant
ovarian cancer cells. PLoS One. 6:e205862011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY
and Cheng AL: Down-regulation of phospho-Akt is a major molecular
determinant of bortezomib-induced apoptosis in hepatocellular
carcinoma cells. Cancer Res. 68:6698–6707. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Woo KJ, Jeong YJ, Park JW and Kwon TK:
Chrysin-induced apoptosis is mediated through caspase activation
and Akt inactivation in U937 leukemia cells. Biochem Biophys Res
Commun. 325:1215–1222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fraser M, Bai T and Tsang BK: Akt promotes
cisplatin resistance in human ovarian cancer cells through
inhibition of p53 phosphorylation and nuclear function. Int J
Cancer. 122:534–546. 2008. View Article : Google Scholar
|
|
38
|
Liu W, Akhand AA, Takeda K, et al: Protein
phosphatase 2A-linked and -unlinked caspase-dependent pathways for
downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell
Death Differ. 10:772–781. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ramos AM, Fernández C, Amràn D, Sancho P,
de Blas E and Aller P: Pharmacologic inhibitors of PI3K/Akt
potentiate the apoptotic action of the antileukemic drug arsenic
trioxide via glutathione depletion and increased peroxide
accumulation in myeloid leukemia cells. Blood. 105:4013–4020. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kornblau SM, Singh N, Qiu Y, et al: Highly
phosphorylated FOX03A is an adverse prognostic factor in acute
myeloid leukemia. Clin Cancer Res. 16:1865–1874. 2010. View Article : Google Scholar : PubMed/NCBI
|
